Guardant Health, INC Form 4 insider transactions

AmirAli Talasaz, Co-Chief Executive Officer of Guardant Health, Inc., reports the vesting and subsequent tax withholding of restricted stock units.

Helmy Eltoukhy, Co-CEO of Guardant Health, reports the vesting and subsequent tax withholding of restricted stock units, resulting in adjustments to his beneficial ownership.

Director Tariq Musa reported selling 116 shares of Guardant Health, Inc. common stock on March 19, 2025, at a price of $43.7 per share.

Director Tariq Musa reported the disposition of 249 shares of Common Stock and 249 Restricted Stock Units of Guardant Health, Inc. on March 15, 2025.

Chief Legal Officer John G. Saia of Guardant Health, Inc. reports the vesting of restricted stock units and subsequent tax withholding.

Director Myrtle S. Potter reports a transaction involving Guardant Health, Inc. common stock on March 15, 2025.

Kumud Kalia, Chief Information Officer of Guardant Health, reports the vesting of restricted stock units, a tax withholding, and a sale of shares.

Chris Freeman, Chief Commercial Officer of Guardant Health, reports the vesting and subsequent tax withholding related to restricted stock units.

Craig Eagle, Chief Medical Officer of Guardant Health, reports the vesting and subsequent tax withholding related to restricted stock units.

Michael Brian Bell, CFO of Guardant Health, Inc., reports the vesting and subsequent tax withholding of restricted stock units.

Co-Chief Executive Officer AmirAli Talasaz reports the disposition and acquisition of Guardant Health, Inc. stock related to the vesting of restricted stock units.

Helmy Eltoukhy, Co-Chief Executive Officer of Guardant Health, reports the vesting of restricted stock units and subsequent tax withholding.

Co-Chief Executive Officer AmirAli Talasaz reports the acquisition of restricted stock units in Guardant Health, Inc.

John G. Saia, Chief Legal Officer of Guardant Health, Inc., reports the acquisition of stock options and restricted stock units.

Chief People Officer Terilyn J. Monroe of Guardant Health, Inc. reports the acquisition of stock options and restricted stock units.

Chief Information Officer Kumud Kalia reports the acquisition of stock options and restricted stock units in Guardant Health, Inc.

Chris Freeman, Chief Commercial Officer of Guardant Health, reports the acquisition of stock options and restricted stock units.

Helmy Eltoukhy, Co-Chief Executive Officer of Guardant Health, Inc., reports the acquisition of restricted stock units on March 12, 2025.

Craig Eagle, Chief Medical Officer of Guardant Health, reports the acquisition of stock options and restricted stock units.

Darya Chudova, Chief Technology Officer of Guardant Health, reports the acquisition of stock options and restricted stock units.

Michael Brian Bell, CFO of Guardant Health, reports the acquisition of stock options and restricted stock units.

Director Meghan Joyce reported the sale of 100 shares of Guardant Health common stock at $42.71 and the exercise of options for 67 shares.

John G. Saia, Chief Legal Officer of Guardant Health, Inc., reports transactions involving common stock and restricted stock units.

Chief People Officer Terilyn J. Monroe reports the vesting of restricted stock units and subsequent tax withholding, resulting in changes to her beneficial ownership of Guardant Health stock.

Kumud Kalia, Chief Information Officer of Guardant Health, reports stock transactions including acquisition and disposal of common stock and vesting of restricted stock units.

Chris Freeman, Chief Commercial Officer of Guardant Health, reports the vesting of performance-based restricted stock units and associated tax withholding.

Craig Eagle, Chief Medical Officer of Guardant Health, reports the vesting of restricted stock units and subsequent tax withholding.

Darya Chudova, Chief Technology Officer of Guardant Health, reports the vesting and subsequent tax withholding of restricted stock units.

Michael Brian Bell, CFO of Guardant Health, reports the vesting of performance-based restricted stock units and subsequent tax withholding.

Director Steve Krognes reports the vesting and acquisition of 154 shares of Guardant Health common stock from restricted stock units on February 28, 2025.